|
?:authorAffiliation
|
-
[\'Chelsea & Westminster Hospital, London, UK.\', \'Department of Infectious Disease, Imperial College London, London, UK.\', \'Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK.\', \'Bloomberg School of Public Health, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.\', \'Drugs for Neglected Diseases Initiative (DNDi), Geneva, Switzerland.\', \'Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.\', \'Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.\', \'Unit of Clinical Pharmacology, ASST Fatebenefratelli, Sacco University Hospital, Milan, Italy.\', \'Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, Alabama, USA.\', \'Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, Colorado, USA.\', \'Centre of Excellence in Long-acting Therapeutics (CELT), University of Liverpool, UK.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}